Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Funding for HCV and public health activities via appropriations. 

Pharmaceutical policy as it relates to payments under the 340B program.  

S.1287 - Viral Hepatitis Testing Act of 2015 Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Access and reimbursement for HCV products
HCR - Health Issues MMM - Medicare/Medicaid VET - Veterans
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS